Market Capitalization (Millions $) |
3,814 |
Shares
Outstanding (Millions) |
228 |
Employees |
- |
Revenues (TTM) (Millions $) |
22 |
Net Income (TTM) (Millions $) |
-73 |
Cash Flow (TTM) (Millions $) |
-57 |
Capital Exp. (TTM) (Millions $) |
1 |
Orchard Therapeutics Plc
Orchard Therapeutics Plc is a biotechnology company specializing in the development of gene therapies for rare diseases. They focus on using ex-vivo autologous hematopoietic stem cell gene therapy to provide potentially curative treatments for patients with severe genetic disorders. Orchard Therapeutics aims to deliver transformative gene therapies that address the underlying cause of the disease and provide long-term benefits for patients. They have a pipeline of programs targeting various inherited disorders, including rare diseases affecting the immune system, blood disorders, metabolic disorders, and neurometabolic disorders. The company is headquartered in London, United Kingdom, and was founded in 2015.
Company Address: 245 Hammersmith Road London 0
Company Phone Number: (0) 203 808-8286 Stock Exchange / Ticker: NASDAQ ORTX
|